Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial
Ivor Elrifi, CEO of Tiziana Life Sciences, expressed enthusiasm about this milestone, stating, "We are excited to initiate this important clinical study with the support of the ALS Association grant.
DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
"Receiving orphan drug designation from the FDA is a significant milestone for DiagnaMed and validates the promise of molecular hydrogen as a potential treatment for ALS. We are excited to partner ...
Four immunoassays for neurofilament light chain show consistent performance in amyotrophic lateral sclerosis
Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...
Blood test can help diagnose, track ALS patients, French study indicates
A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...
Science Daily6d
Blood test could lead to better diagnosis and management of ALS
Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis. Neurology , 2025; 104 (6) DOI: 10.1212/WNL.0000000000213400 Cite This Page : ...
emjreviews.com2d
Tetramethylpyrazine Nitrone Benefits Grip Strength in Younger Patients with ALS
Tetramethylpyrazine nitrone is safe for ALS and may slow grip strength decline, especially in younger patients.
Medpage Today on MSN5d
Novel Agent Safe in ALS, Phase II Study Suggests
Tetramethylpyrazine nitrone was safe for people with amyotrophic lateral sclerosis (ALS), but neither a high nor low daily ...
Inside the Manhattan Home Where Legendary Singer Roberta Flack Passed Away at Age 88
Legendary "If Ever I See You Again" singer Roberta Flack has passed away at the age of 88 at her home in Manhattan surrounded ...